Showing 1 - 3 results of 3 for search 'Inka Pawlitzky', query time: 0.02s Refine Results
  1. 1
    Analysis of mice lacking DNaseI hypersensitive sites at the 5' end of the IgH locus.

    Analysis of mice lacking DNaseI hypersensitive sites at the 5' end of the IgH locus. by Thomas Perlot, Inka Pawlitzky, John P Manis, Ali A Zarrin, Peter H Brodeur, Frederick W Alt

    Published 2010-11-01
    Get full text
    Article
  2. 2
    P542: A PHASE I/II STUDY TO ASSESS SAFETY, TOLERABILITY AND PRELIMINARY EFFICACY OF BEXMARILIMAB IN COMBINATION WITH STANDARD OF CARE IN PATIENTS WITH MYELOID MALIGNANCIES (BEXMAB)

    P542: A PHASE I/II STUDY TO ASSESS SAFETY, TOLERABILITY AND PRELIMINARY EFFICACY OF BEXMARILIMAB IN COMBINATION WITH STANDARD OF CARE IN PATIENTS WITH MYELOID MALIGNANCIES (BEXMAB) by Mika Kontro, Timo Siitonen, Johanna Rimpilainen, Marja Pyorala, Inka Pawlitzky, Sofia Aakko, Marie-Louise Fjaellskog, Maija Hollmén, Naval Daver

    Published 2023-08-01
    Get full text
    Article
  3. 3
    Assessing the safety, tolerability and efficacy of PLGA-based immunomodulatory nanoparticles in patients with advanced NY-ESO-1-positive cancers: a first-in-human phase I open-label dose-escalation study protocol

    Assessing the safety, tolerability and efficacy of PLGA-based immunomodulatory nanoparticles in patients with advanced NY-ESO-1-positive cancers: a first-in-human phase I open-labe... by Mark R Middleton, Winald R Gerritsen, Ian Walters, Licia Rivoltini, Niven Mehra, Jeroen H A Creemers, Carl G Figdor, I Jolanda M de Vries, Uzi Gileadi, Inka Pawlitzky, Konstantina Grosios, Petronella B Ottevanger

    Published 2021-11-01
    Get full text
    Article

Search Tools: